Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones de la editorial AMER ASSOC CANCER RESEARCH

Tipo Año Título Fuente
Artículo2024High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic ProgenitorsCANCER PREVENTION RESEARCH
Resumen congreso2024R-loop type determines the orientation of transcription-replication conflicts attenuated by transcription factor IISCANCER RESEARCH
Artículo2024Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.CLINICAL CANCER RESEARCH
Resumen congreso2023A tumor-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancerCANCER RESEARCH
Editorial2023Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238CLINICAL CANCER RESEARCH
Resumen congreso2023Primary results of SOLTI-1503 PROMETEO phase 2 trial of Combination of Talimogene Laherparepvec (T-VEC) with Atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapyCANCER RESEARCH
Artículo2023Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.CLINICAL CANCER RESEARCH
Resumen congreso2023Unicentric experience with icdk4/6 in metastatic breast cancerCANCER RESEARCH
Artículo2022Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target InhibitionCANCER RESEARCH
Artículo2022Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker SubanalysisCLINICAL CANCER RESEARCH
Artículo2022mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive breast cancer.MOLECULAR CANCER RESEARCH
Artículo20215-year outcomes with cobimetinib plus vemurafenib in BRAFV600 mutation⇓positive advanced melanoma: extended follow-up of the coBRIM studyCLINICAL CANCER RESEARCH
Artículo2021MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid LeukemiaCANCER RESEARCH
Artículo2021Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapyCLINICAL CANCER RESEARCH
Artículo2021R-loop-mediated ssDNA breaks accumulate following short-term exposure to the HDAC inhibitor romidepsin.MOLECULAR CANCER RESEARCH
Artículo2020A somatostatin receptor subtype-3 (SST3) peptide agonist shows antitumor effects in experimental models of nonfunctioning pituitary tumorsCLINICAL CANCER RESEARCH
Artículo2020Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGF beta-Induced Breast Cancer MetastasisCLINICAL CANCER RESEARCH
Revisión2020PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical PracticeCLINICAL CANCER RESEARCH
Resumen congreso2020SOLTI-1503 PROMETEO: Combination of talimogene laherparepvec (T-VEC) with atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapyCANCER RESEARCH
Artículo2020STAT3-Mediated Astrocyte Reactivity Associated with Brain Metastasis Contributes to Neurovascular DysfunctionCANCER RESEARCH
Resumen congreso2019Biomarker analysis by baseline circulating tumor DNA alterations in the MONALEESA-3 studyCANCER RESEARCH
Artículo2019Development of therapeutic anti-JAGGED1 antibodies for cancer therapyMOLECULAR CANCER THERAPEUTICS
Artículo2019Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcomaCLINICAL CANCER RESEARCH
Resumen congreso2019Ribociclib plus letrozole in patients with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2) advanced breast cancer (aBC) with no prior endocrine therapy (ET) for ABC: CompLEEment-1 trial, preliminary results from Spanish populationCANCER RESEARCH
Artículo2019The antitumor drugs trabectedin and lurbinectedin induce transcription-dependent replication stress and genome instabilityMOLECULAR CANCER RESEARCH
Artículo2019VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary TumorsCLINICAL CANCER RESEARCH
Artículo2019Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) PolymorphismsCLINICAL CANCER RESEARCH
Resumen congreso2018A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-BreastCANCER RESEARCH
Artículo2018AR Expression in Breast Cancer CTCs Associates with Bone MetastasesMOLECULAR CANCER RESEARCH
Resumen congreso2018Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE studyCANCER RESEARCH
Artículo2017The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMBCLINICAL CANCER RESEARCH
Ponencia2016Characterization of circulating monocyte infiltration in brain metastasisCANCER RESEARCH
Resumen congreso2016DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypesCANCER RESEARCH
Resumen congreso2016Epigenetic profiling uncovers the suppressive role of caveolae in Ewing sarcomaCANCER RESEARCH
Resumen congreso2016Epigenomic profiling identifies NCRNAs as novel tumor suppressors in developmental tumorsCANCER RESEARCH
Artículo2016Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical TrialCLINICAL CANCER RESEARCH
Artículo2016Loss of PKCδ induces prostate cancer resistance to Paclitaxel through activation of Wnt/beta-catenin pathway and Mcl-1 accumulationMOLECULAR CANCER THERAPEUTICS
Ponencia2016Polymerase kappa determines the sensitivity of MTH1 inhibitors to cisplatin-resistant cellCANCER RESEARCH
Artículo2016Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)CLINICAL CANCER RESEARCH
Resumen congreso2016Unveiling the relationship between the SWI/SNF chromatin remodeling complex and noncoding RNAsCANCER RESEARCH
Letter2015Bufalin Is a Steroid Receptor Coactivator Inhibitor-LetterCANCER RESEARCH
Resumen congreso2015Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancerCANCER RESEARCH
Artículo2015Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerCLINICAL CANCER RESEARCH
Artículo2015MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NF kappa B Activation in Breast CancerMOLECULAR CANCER THERAPEUTICS
Artículo2015Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2(-/-)IL2R gamma(null) Immunodeficient MiceCANCER RESEARCH
Resumen congreso2015Prospective study of the impact of the Prosigna (TM) assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM studyCANCER RESEARCH
Artículo2015Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling AgentsCLINICAL CANCER RESEARCH
Artículo2014Activated ERBB2/HER2 Licenses Sensitivity to Apoptosis upon Endoplasmic Reticulum Stress through a PERK-Dependent PathwayCANCER RESEARCH
Artículo2014Prostate cancer cell response to Paclitaxel is affected by abnormally expressed securin PTTG1MOLECULAR CANCER THERAPEUTICS
Artículo2014Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue OriginsCLINICAL CANCER RESEARCH
Ponencia2011The multitasking of Sox2: Maintaining the stemness and inducing the malignant phenotype of gliomasCANCER RESEARCH
Artículo2010MSH6 and MUTYH Deficiency Is a Frequent Event in Early-Onset Colorectal CancerCLINICAL CANCER RESEARCH
Artículo2010Regulation of the MicroRNA Processor DGCR8 by the Tumor Suppressor ING1CANCER RESEARCH
Revisión2009Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?CANCER RESEARCH
Artículo2009Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Nonmalignant Asbestos-Related Pleural Disease: Relation with Past Asbestos ExposureCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Artículo2008A pivotal role for heat shock protein 90 in Ewing Sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo studyCANCER RESEARCH
Artículo2006Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cellsCANCER RESEARCH
Editorial2006Hypoxia-inducible factor 1 as a possible target for cancer chemopreventionCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Artículo2006Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumorCLINICAL CANCER RESEARCH
Artículo2006VRK1 Signaling pathway in the context of the proliferation phenotype in Head and Neck squamous cell carcinomaMOLECULAR CANCER RESEARCH
Artículo2005Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H : quinone oxidoreductase 1 levelsCLINICAL CANCER RESEARCH
Letter2005Imatinib is not a potential alternative treatment for uterine leiomyosarcomaCLINICAL CANCER RESEARCH
Artículo2004Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell Factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosisCLINICAL CANCER RESEARCH
Artículo1995Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotypeCELL GROWTH & DIFFERENTIATION